Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

• Glavni autori: Shuai Wang (Autor), Chongming Wu (Autor), Xin Li (Autor), Yue Zhou (Autor), Quanyang Zhang (Autor), Fuchao Ma (Autor), Jianhe Wei (Autor), Xiaopo Zhang (Autor), Peng Guo (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2017-07-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder,...